High levels of Schistosoma mansoni infections among schoolchildren in central Sudan one year after treatment with praziquantel
- 8 June 2011
- journal article
- research article
- Published by Cambridge University Press (CUP) in Journal of Helminthology
- Vol. 86 (2), 228-232
- https://doi.org/10.1017/s0022149x11000290
Abstract
A longitudinal study was conducted to evaluate the impact of praziquantel (PZQ) for the treatment of Schistosoma mansoni infection among schoolchildren in Al Gunaid in Central Sudan. A cohort of schoolchildren (6–15 years of age) was investigated before and 1 year after treatment with a single dose of PZQ 40 mg/kg. Parasitological examinations for S. mansoni were performed before and after treatment, and prevalence and intensity of infection were analysed. Of 2741 schoolchildren recruited from six elementary schools at baseline, 2521 were successfully traced and re-examined at follow-up, with two complete sets of longitudinal parasitological data on S. mansoni. Boys showed significantly higher prevalence of S. mansoni infection than girls. A single dose of PZQ reduced the overall prevalence of S. mansoni infection by 36.7% (from 59.1 to 37.4%) and the intensity of infection by 41.1% (from 116.7 to 68.7 eggs per gram of stool) 1 year after treatment. The reduction in prevalence was significantly higher among the group of children with heavy infections (by 76.1%, from 6.7 to 1.6%) and among girls (by 54.1%, 42.3 to 19.4%) at 1 year after treatment. Thus, in spite of a significant reduction in the prevalence and intensity of S. mansoni infection 1 year after PZQ treatment, the prevalence of the disease was still high and further research is needed on this topic.Keywords
This publication has 16 references indexed in Scilit:
- In Vitro Praziquantel Test Capable of Detecting Reduced In Vivo Efficacy in Schistosoma mansoni Human InfectionsThe American Journal of Tropical Medicine and Hygiene, 2010
- High prevalence ofSchistosomahaematobiuminfection in Gereida Camp, in southern Darfur, SudanPathogens and Global Health, 2009
- Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern SudanTransactions of the Royal Society of Tropical Medicine and Hygiene, 2009
- Schistosoma mansoniinfection as a predictor of severe anaemia in schoolchildren in eastern SudanJournal of Helminthology, 2009
- Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina FasoBulletin of the World Health Organization, 2008
- Impact on a national helminth control programme on infection and morbidity in Ugandan schoolchildrenBulletin of the World Health Organization, 2007
- Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at riskThe Lancet Infectious Diseases, 2006
- Clinical trials in parasitic diseasesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2004
- Characterization of Isolates of Schistosoma mansoni from Egyptian Villagers that Tolerate High Doses of PraziquantelThe American Journal of Tropical Medicine and Hygiene, 1996
- Efficacy and Side Effects of Praziquantel in an Epidemic Focus of Schistosoma mansoniThe American Journal of Tropical Medicine and Hygiene, 1995